Literature DB >> 11303627

CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas.

C de la Guardia1, C A Casiano, J Trinidad-Pinedo, A Báez.   

Abstract

BACKGROUND: Antibodies against cancer-related genes have been detected in human cancers including head and neck cancers. High titers of c-Myc autoantibodies have been linked to gene amplification and tumor progression. Centromere protein-F (CENP-F) autoantibodies have been detected in patients with various cancers, suggesting similar gene alteration.
METHODS: CENP-F and c-MYC amplification was assessed in 72 head and neck squamous cell carcinoma (HNSCC) patients. Tumor and matched mucosa from 22 patients were analyzed for CENP-F mRNA levels by RT-PCR.
RESULTS: The larynx was the site most altered by amplification of either gene. CENP-F and c-MYC were amplified in 11% and 17% of the tumors, respectively. Coamplification was found in 7% of the tumors, most of which showed regional node involvement. CENP-F mRNA was overexpressed in 36% of tumors, and 23% of paired mucosa.
CONCLUSION: Our results provide the first evidence that CENP-F gene is amplified and overexpressed in HNSCC. No correlation was noted between CENP-F amplification and clinicopathologic parameters. However, CENP-F overexpression correlated with nodal metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11303627     DOI: 10.1002/1097-0347(200102)23:2<104::aid-hed1005>3.0.co;2-0

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  16 in total

1.  Integrative gene set analysis: application to platinum pharmacogenomics.

Authors:  Brooke L Fridley; Ryan Abo; Xiang-Lin Tan; Gregory D Jenkins; Anthony Batzler; Ann M Moyer; Joanna M Biernacka; Liewei Wang
Journal:  OMICS       Date:  2013-11-07

2.  CAAX-box protein, prenylation process and carcinogenesis.

Authors:  Juehua Gao; Jie Liao; Guang-Yu Yang
Journal:  Am J Transl Res       Date:  2009-05-25       Impact factor: 4.060

Review 3.  Cenp-F (mitosin) is more than a mitotic marker.

Authors:  Asta Varis; Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2006-03-25       Impact factor: 4.316

4.  Comparative analysis of algorithms for integration of copy number and expression data.

Authors:  Riku Louhimo; Tatiana Lepikhova; Outi Monni; Sampsa Hautaniemi
Journal:  Nat Methods       Date:  2012-02-12       Impact factor: 28.547

5.  RNAi mediated acute depletion of retinoblastoma protein (pRb) promotes aneuploidy in human primary cells via micronuclei formation.

Authors:  Angela Amato; Laura Lentini; Tiziana Schillaci; Flora Iovino; Aldo Di Leonardo
Journal:  BMC Cell Biol       Date:  2009-11-02       Impact factor: 4.241

6.  Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.

Authors:  Muy-Teck Teh; Emilios Gemenetzidis; Tracy Chaplin; Bryan D Young; Michael P Philpott
Journal:  Mol Cancer       Date:  2010-02-26       Impact factor: 27.401

Review 7.  Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma.

Authors:  Jian-Ying Zhang
Journal:  Autoimmun Rev       Date:  2006-10-10       Impact factor: 9.754

8.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

Authors:  Jörg van den Boom; Marietta Wolter; Rork Kuick; David E Misek; Andrew S Youkilis; Daniel S Wechsler; Clemens Sommer; Guido Reifenberger; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.

Authors:  Yongmei Li; Zhi Zhu; Shuhui Zhang; Danghui Yu; Hongyu Yu; Lina Liu; Xiaozhe Cao; Li Wang; Hengjun Gao; Minghua Zhu
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

10.  Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression.

Authors:  Wen-Ting Liao; Chun-Ping Yu; Dong-Hui Wu; Ling Zhang; Li-Hua Xu; Gui-Xiang Weng; Mu-Sheng Zeng; Li-Bing Song; Jin-Song Li
Journal:  J Exp Clin Cancer Res       Date:  2009-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.